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Epigenetic targetBromodomains are protein modules that selectively recognize histones by binding to acetylated
lysines. Here, we have carried out multiple molecular dynamics simulations of 20 human bromod-
omains to investigate the ﬂexibility of their binding site. Some bromodomains show alternative side
chain orientations of three evolutionarily conserved residues: the Asn involved in acetyl-lysine
binding and two conserved aromatic residues. Furthermore, for the BAZ2B and CREBBP bromodo-
mains we observe occlusion of the binding site which is coupled to the displacement of the two aro-
matic residues. In contrast to available structures, the simulations reveal large variability of the
binding site accessibility. The simulations suggest that the ﬂexibility of the bromodomain binding
site and presence of self-occluded metastable states inﬂuence the recognition of acetyl-lysine on
histone tails.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Bromodomains, protein modules of about 110 residues, recog-
nize acetylated lysine side chains mainly in histones and are thus
involved in transcriptional regulation [1,2]. In the human genome
there are 46 proteins with a total of 61 different bromodomains,
with up to six bromodomains per protein [3]. Due to the potential
role of bromodomains in tumors and inﬂammation [4–6], large
scale structural studies have been carried out with the ultimate
goal to facilitate the discovery of small-molecule inhibitors able
to interfere in the process of reading acetylated lysine [7]. Since
1999, when the ﬁrst three-dimensional structure of a human
bromodomain was solved [8], the crystal and/or solution struc-
tures of more than 40 human bromodomains have been reported
[9,10]. All available structures show a conserved four-helix bundle
topology (Fig. 1) in which the ZA-loop and BC-loop connect the ﬁrst
two a helices (called Z and A) and last two a helices (called B and
C), respectively [10,11]. The acetyl-lysine binding site is very sim-
ilar in all structures of bromodomains [10]. The BC-loop contrib-
utes the evolutionary conserved Asn side chain [12] which acts
as hydrogen bond donor to the acetylated lysine side chain. More-
over, two conserved Tyr residues [13] are present in the ZA-loop
and BC-loop, respectively (Fig. S1). In striking contrast to the abun-
dance of available three-dimensional structures, there are only few
computational studies on bromodomains [14–16]. In particular, it
seems that the dynamic properties of human apo bromodomainshave not been investigated yet by atomistic simulations. Here,
we have studied the binding site ﬂexibility of 20 bromodomains
(covering seven of the eight families of human bromodomains)
by explicit solvent MD simulations. The simulation results reveal
a surprisingly high heterogeneity of the plasticity and accessibility
of the acetyl-lysine binding site.
2. Results and discussion
A sequence alignment of the 20 simulated bromodomains with
indication of important structural features and investigated key
residues is given in Fig. S1. Family memberships are listed in
Table S-I. The time series of root mean square deviation (RMSD)
of the Ca atoms show that the overall fold of the simulated brom-
odomains is stable over the 1-ls time scale and 310 K temperature
of the MD runs (Fig. S2). Most of the ﬂuctuations are localized in
the ZA-loop, BC-loop, and the termini (Fig. S3). The ZA-loop and
BC-loop are involved in binding the histone tail whereas the ter-
mini are located far away from the acetyl-lysine binding site so
that their motion can be neglected. Importantly, we observe multi-
ple events of reversible rotation of the side chains investigated in
the present study along the 0.5- to 1-ls time scale of the MD runs
(Figs. S4 and S5). These rotations take place on a time scale about
one order of magnitude smaller than the length of the simulations
so that the following analysis is not marred by statistical errors.
We ﬁrst investigated the ﬂexibility of the conserved Asn which
is directly involved in acetyl-lysine binding (i.e., Asn1944 in BAZ2B,
Asn1168 in CREBBP, Asn1604 in TAF1(2), etc.). For most of the
bromodomains studied here, there are many events of reversible
Fig. 2. Rotational ﬂexibility of the conserved Asn side chain as observed in MD simulati
conserved Asn (red) and distance between Asn side chain and residue n-4 upstream (bl
Fig. 1. Ribbon illustration of the crystal structure of the complex between CREBBP
and acetyl-lysine (PDB code 3P1C). Each of the four a-helices and two binding site
loops is displayed with a different color. The side chains of the conserved Tyr1125 of
the ZA-loop, and Tyr1167-Asn1168 of the BC-loop are emphasized (sticks) together
with the side chain of acetyl-lysine (sticks, light colors). The N-terminus and C-
terminus are shown with a blue and red sphere, respectively.
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S5). The rotation (of about 180 degrees) around the v2 angle of the
conserved Asn switches between an orientation in which the side
chain –NH2 group caps the C-terminal turn of a helix B (by donat-
ing a hydrogen bond to the backbone carbonyl of the n-4 upstream
residue, e.g., the hydrogen bond between the Asn1168 side chain
and the carbonyl group of residue 1164 in CREBBP) to a completely
solvent exposed orientation of the –NH2 group (Fig. 2, top). Note
that the former orientation is observed in most (13 of 17) X-ray
structures of the apo bromodomains used in this study (three of
them have Thr (PHIP(2) and WDR9(2)) or Tyr (ASH1L) instead of
the conserved Asn), as well as in the X-ray structures of BRD4(1)
with three different diacetylated peptides (PDB codes 3UVW,
3UVY, and 3UW9) and in the CREBBP/acetyl-lysine complex (PDB
code 3P1C). Interestingly, in seven of the 17 bromodomains the
Asn –NH2 group is oriented towards the solvent during more than
one third of the simulation time (Figs. S4 and S5). These bromodo-
mains are: TAF1L(2) (90% of the snapshots with solvent-exposed
orientation of the Asn –NH2 group), TAF1(2) (81%), TAF1(1)
(68%), GCN5L2 (44%), ATAD2 (43%), BAZ2B (39%), and PB1(2)
(38%). For TAF1L(2), TAF1(2), and TAF1(1) (all belonging to a single
clade of family VII in the bromodomain phylogenetic tree [10]) the
solvent exposed orientation of the Asn -NH2 group is stabilized by
a water-bridged hydrogen bond between the Asn side chain car-
bonyl and the hydroxyl group of the Ser in position n-4 upstream
(Fig. 2, bottom). It has to be noted that most bromodomains have
Ala or Cys at position n-4 upstream of the conserved Asn so that
these side chains cannot form a (water-bridged) hydrogen bond.
Note also that an in-depth analysis of the water molecules in theons of CREBBP (top) and TAF1(2) (bottom). (Middle) Time series of Asn v2 angle of
ack). (Left and right) Representative MD snapshots.
2160 S. Steiner et al. / FEBS Letters 587 (2013) 2158–2163binding site along the MD trajectories goes beyond the scope of
this paper and will be presented elsewhere together with a com-
parison with the ﬁve water molecules that seem to be conserved
in the crystal structures [10].
We further analyzed the motion of residues adjacent to the con-
served Asn to shed light onto the accessibility of the acetyl-lysine
binding site. The MD trajectories of some of the 20 simulated
bromodomains unmask a large ﬂexibility of the side chain of the
evolutionary conserved Tyr (Phe in BAZ2B and SMARCA4) in the
BC-loop, i.e., the residue preceding in the sequence the Asn in-
volved in acetyl-lysine binding (Figs. S4 and S5). The side chain
of this Tyr (or Phe) rotates from an inward orientation in which
the aromatic ring is part of the binding site surface (v1 angle in
trans) to an outward orientation in which the same side chain
points towards the exterior surface of the bromodomain (v1 angle
values around 60 degrees) (Fig. 3). The ﬁve bromodomains with a
population larger than 10% of the outward orientation of the BC-
loop Tyr (or Phe) side chain are BRDT(1) (100%), CREBBP (31%),
BAZ2B (24%), SMARCA4 (21%), and BRD1 (11%). This simulation re-Fig. 3. Swapping out of the aromatic residue preceding the conserved Asn in the BC-loo
Two-dimensional histograms of binding site solvent accessible surface area (SASA) ver
horizontal line at 100 Å2 is an arbitrary threshold drown solely to help the eye. The cya
corresponding to the cyan and red structures, respectively, in panel (a). The black to yellow
bar. (c) Time series of four geometrical variables used to analyze the binding site. This pa
shown in Figs. S7–S10. The variables are the RMSD of the Ca atoms of the ZA-loop from th
(blue, running average calculated over time intervals of 10 ns for clarity), and the distan
side chain (green).sult is a novel ﬁnding because only two of the more than 50 brom-
odomain crystal and solution structures (i.e., the X-ray structure of
BRDT(1) and the NMR structure of KIAA1240, PDB codes 2RFJ and
2DKW, respectively) show a similar outward orientation of the side
chain of the conserved Tyr on the BC-loop. Note that in contrast to
the solution structure, the crystal structure of KIAA1240 (PDB code
3LXJ) does not show the outward orientation of the conserved Tyr.
To further investigate the inﬂuence of the displacement of the
BC-loop Tyr on the binding site accessibility, two-dimensional his-
tograms were calculated for each of the 20 simulated bromodo-
mains (Figs. 3(b) and S6). According to the two-dimensional
histograms the 20 bromodomains can be assigned to three differ-
ent groups. The largest group consists of the bromodomains with
an open binding site, and in which the side chain of the conserved
Tyr of the BC-loop is part of the binding site surface (v1 angle al-
ways in the trans orientation, e.g., TAF1(2)). The second group in-
cludes the bromodomains in which the conserved Tyr changes its
orientation without affecting the binding site accessibility (e.g.,
BRD1 and SMARCA4). The third group includes the bromodomainsp. (a) Representative snapshots extracted from the MD simulations of CREBBP. (b)
sus side chain v1 angle of the conserved Tyr (Phe in BAZ2B) in the BC-loop. The
n and red rectangles in the histogram of CREBBP emphasize the metastable states
coloring of frequency values follows a logarithmic scale and is shown in the legend
nel shows run 2 of BAZ2B while the equivalent time series for the other MD runs are
e crystal structure (black), the Phe1943 v1 dihedral angle (red), the binding site SASA
ce between the hydroxyl oxygen of Tyr1901 and the nitrogen atom of the Asn1944
S. Steiner et al. / FEBS Letters 587 (2013) 2158–2163 2161in which the outward orientation of the BC-loop Tyr promotes a
rearrangement of other binding site residues resulting in a partially
occluded, i.e., shallower binding site (e.g., BAZ2B and CREBBP,Fig. 4. Occlusion of the acetyl-lysine binding site by the conserved Tyr of the ZA-
loop. (a) The ribbon structure is a representative MD snapshot of the CREBBP
simulations in which the conserved Tyr of the ZA-loop is involved in a hydrogen
bond with the Asn that binds acetyl-lysine. The three conserved side chains (sticks)
are shown together with three water molecules (red spheres). The position of
acetyl-lysine (light-colored sticks) and three water molecules (light red spheres)
from the crystal structure of the CREBBP/acetyl-lysine complex (PDB code 3P1C)
was obtained by structural superposition of the Ca atoms. Surface representation of
a representative MD snapshot with partially occluded, i.e., shallower, binding site
(b) and the crystal structure of CREBBP (PDB code 3P1C) (c). The color coding
reﬂects atomic elements (carbon, nitrogen, and oxygen atoms in yellow, blue, and
red, respectively). The location of the acetyl-lysine binding site is indicated with a
black oval.Figs. 3(b) and 4). More precisely, one observes large ﬂuctuations
of the ZA-loop that are associated frequently with the swapping
out of the BC-loop Tyr (Figs. 3(c), S7 and S8) and with changes in
the accessibility of the binding site (Figs. S9 and S10). In particular,
in the BAZ2B and CREBBP simulation segments during which the
conserved Tyr of the BC-loop points outward, the conformational
plasticity of the ZA-loop results (in 20% to 25% of the saved snap-
shots) in the formation of a direct hydrogen bond between
Asn1168 and ZA-loop Tyr1125 in CREBBP (Figs. 3(c) and 4), and
Asn1944 and ZA-loop Tyr1901 in BAZ2B. Note that these two side
chains are separated by two water molecules in the X-ray struc-
tures (PDB codes 3DWY and 3G0L). In essence, it emerges from
the MD trajectories that the ZA-loop Tyr side chain can occupy
the same position and can be stabilized by the same hydrogen
bond to Asn as the natural ligand acetyl-lysine (Fig. 4).
The ZA-loop shows signiﬁcant plasticity and large deviations
from the crystal structure (Figs. 3(c), S7 and S8). This ﬂexibility is
consistent with the structural heterogeneity of the ZA-loop ob-
served by overlapping the available X-ray structures [10] as well
as with the length of the ZA-loop (about 25–30 residues, Fig. S1).
Figs. 3(c), S9 and S10 show that the displacement of the ZA-loop
inﬂuences the binding site accessibility (note that 4 of the 6 resi-
dues used to calculate the binding site accessibility are in the ZA-
loop). In particular, the accessibility can change signiﬁcantly in
the MD trajectory segments during which the ZA-loop RMSD from
the crystal structure is large, while the accessibility is less variable
in segments with mainly rigid ZA-loop. Interestingly, the ZA-loop
conformational ﬂexibility has been shown to play an important
role at the protein-protein interface for HIV-1 Tat binding to brom-
odomain PCAF [14]. In the present simulations of CREBBP and
BAZ2B, the rearrangement of the ZA-loop and thus of several resi-
dues lining the binding site reduces its aperture which could hin-
der histone peptide recognition.
In conclusion, the MD trajectories reveal a heterogeneous ﬂex-
ibility of the acetyl-lysine binding site in different bromodomains.
The analysis of the trajectories shows that the accessibility of the
binding site ranges from fully preserved (for the majority of brom-
odomains) to almost completely inaccessible during simulation
segments of hundreds of ns (e.g., in BAZ2B and CREBBP). Of practi-
cal importance, the presence of metastable states in a small subset
of bromodomains can be exploited [17–19] to design selective
small-molecule inhibitors few of which have been reported as of
today [4,20–23]. The present simulation results shed some light
on the binding mechanism of histone tails to bromodomains which
seems to be mainly conformational selection, though a (partial) in-
duced ﬁt cannot be deﬁnitively excluded. More precisely, with the
present simulations of apo bromodomains it is not possible to ex-
clude a ligand-promoted displacement of some of the side chains
in the acetyl-lysine binding site. The self-occluded conformation
of the acetyl-lysine binding groove suggests a possible auto-regu-
latory mechanism of histone tail recognition and binding.3. Methods
The coordinates of the 20 bromodomains were downloaded
from the protein database [24]. To reproduce neutral pH conditions
the side chains of aspartates and glutamates were negatively
charged, those of lysines and arginines were positively charged,
and the histidine side chains were neutral. For each bromodomain
the crystal water molecules close to the binding site and with low
B factor value were kept while the remaining water molecules
were deleted. For most bromodomains a B-factor of 15 Å2 was used
as threshold for keeping crystallographic water molecules. For the
few bromodomains with overall higher B-factors a threshold of
30 Å2 was used. With this arbitrary choice of thresholds between
2162 S. Steiner et al. / FEBS Letters 587 (2013) 2158–21634 and 15 crystal water molecules were retained for each bromod-
omain. Importantly, in our simulations the structured water mole-
cules exchange rapidly (residence times ranging from 0.01 to 1 ns)
with the water molecules in the bulk solvent. Furthermore, in test
simulations without crystal water molecules, bulk water molecules
rapidly occupied the conserved positions in the binding site. Thus,
the exact number of kept crystal waters does not inﬂuence the re-
sults of our simulations because individual runs have a length of
0.5 or 1 ls.
Subsequently, the structure was solvated in a water box whose
size was chosen to have a minimal distance of 11 Å between the
boundary and any atom of the protein. Solvation water molecules
within 2.4 Å of any heavy atom of the protein or crystal water were
removed. The simulation system contained sodium and chloride
ions to approximate an ionic strength of about 150 mM and to
compensate for the total charge of each bromodomain. The MD
simulations were carried out with Gromacs 4.5.4 [25] using the
CHARMM PARAM22 force ﬁeld [26] and the TIP3P model of water
[27].
Periodic boundary conditions were applied and electrostatic
interactions were evaluated using the particle-mesh Ewald sum-
mation method [28]. The van der Waals interactions were trun-
cated at a cutoff of 10 Å. The temperature of 310 K was kept
constant by an external bath with velocity rescaling [29] and the
pressure was kept close to 1 atm by the Berendsen barostat. The
SHAKE algorithm was used to ﬁx the covalent bonds involving
hydrogen atoms. The integration time step was 2 fs and snapshots
were saved every 10 ps and 4 ps for the 1-ls and 0.5-ls runs,
respectively.
Multiple independent MD runs of 1 ls each were carried out for
four bromodomains belonging to four different families: BAZ2B
(family V), BRD1 (IV), CREBBP (III), and TAF1(2) (VII). In addition,
16 bromodomains covering all but one of the families were simu-
lated for 0.5 ls each (Table S-I). The crystal structures solved by
the Structural Genomics Consortium [10] were used as starting
conformations.
The solvent accessible surface area (SASA) was calculated with
the SURF tool of Wordom, using the GEPOL algorithm [30,31] and
1.4 Å as radius of the water probe. The following procedure was
used to deﬁne the acetyl-lysine binding site for the SASA calcula-
tion. First, using the X-ray structure of the CREBBP/acetyl-lysine
complex (PDB code 3P1C) residues were selected which had at
least three heavy atoms within 6 Å of the ligand. From this set
Tyr1167 and Asn1168 were excluded to avoid redundancy in the
two variables used for the two-dimensional histograms. Of the
six remaining residues (Pro1110, Phe1111, Val1115, Tyr1125,
Ala1164, Val1174), only the side chain atoms were used to evalu-
ate the binding site SASA. For the other bromodomains the equiv-
alent residues upon structural overlap were chosen. Robustness of
the selection of binding site residues is shown in Fig. S11.
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